Showing posts with label Breakthrough Prize. Show all posts
Showing posts with label Breakthrough Prize. Show all posts

Monday, December 5, 2016

Breakthrough Prizes for Life Scientists

reposted from


Breakthrough Prizes for Life Scientists

Awards of $3 million each go to five researchers in the life sciences, recognizing their pioneering work on autophagy, DNA-damage response, Wnt signaling, and more.
By  | December 5, 2016
Roeland Nusse accepts a Breakthrough Prize.TWITTER, STANFORD MEDICINEStephen Elledge of Harvard Medical School, the University of California, Santa Cruz’s Harry Noller, Roeland Nusse of Stanford University, Yoshinori Ohsumi of Tokyo Institute of Technology, and Huda Zoghbi of Baylor College of Medicine have won 2017 Breakthrough Prizes in Life Sciences. Each award, given yesterday (December 4) during a televised ceremony held in California, is worth $3 million.
Elledge is honored for his pioneering work on DNA-damage response. In 2015, he won a Lasker Award for basic medical research in recognition of his achievements in the field. “I’m truly honored to receive the Breakthrough Prize,” Elledge said in a statement. “It is deeply gratifying to see the profound impact that basic research can have not only in promoting scientific knowledge but also in improving human health.”
Noller is recognized “for discovering the centrality of RNA in forming the active centers of the ribosome,” according to the Breakthrough Prize announcement.

Nusse is honored for his work on Wnt signaling. “This is a complete surprise,” Nusse said in a press release. “My gratitude goes out to many people — my past and present postdoctoral scholars and graduate students and my former mentors have all contributed to the success of my research.”

Ohsumi, who this year won the Nobel Prize in Physiology or Medicine for his pioneering autophagy research, has won a Breakthrough Prize in recognition of his achievements in the field. In 2012, he won a Kyoto Prize in Basic Sciences.
Zoghbi is honored “for discoveries of the genetic causes and biochemical mechanisms of spinocerebellar ataxia and Rett syndrome, findings that have provided insight into the pathogenesis of neurodegenerative and neurological diseases,” according to the announcement. This year she won a Shaw Prize in Life Science and Medicine. “Sometimes rare diseases can really teach you something that's very helpful for more common diseases whose development and treatment has been elusive,” Zoghbi said during the Breakthrough Prize ceremony, according to The Washington Post.
Now in their fifth year, the Breakthrough Prizes are awarded annually to highlight achievements in the life sciences, mathematics, physics, and education. Winners are chosen by selection committees made up of previous Breakthrough Prize laureates.
“There has never been a more important time to support science,” Breakthrough Prize cofounder Mark Zuckerberg, chief executive officer of Facebook, said in the prize announcement. 

CRISPR Pioneers Honored :: Influential researchers receive the 2015 Breakthrough Prizes in Life Sciences.

reposted from http://www.the-scientist.com/?articles.view/articleNo/41455/title/CRISPR-Pioneers-Honored/



CRISPR Pioneers Honored

Influential researchers receive the 2015 Breakthrough Prizes in Life Sciences.
By  | November 18, 2014
312
Emmanuelle Charpentier, Jennifer Doudna, and Victor Ambros, recipients of 2015 Breakthrough Prizes in Life Sciences.BREAKTHROUGH PRIZE
The 2015 Breakthrough Prizes in Life Sciences recognized six scientists for their achievements in gene editing, gene regulation, and Parkinson’s therapy. The $3 million prizes are sponsored by a group of tech billionaires, including Russian entrepreneur Yuri Milner, Mark Zuckerberg of Facebook, and Sergey Brin of Google. The prizes were awarded earlier this month (November 9) at a televised ceremony in Mountain View, California.
Emmanuelle Charpentier of the Helmholtz Center for Infection Research in Germany and Umeå University in Sweden, and Jennifer Doudna of the University of California, Berkeley, were honored for discovering the details of CRISPR, a bacterial antiviral system that has been widely adapted for genetic engineering.
Doudna was “thrilled and shocked and very excited” to learn of the award, she told The Guardian. “We published our work in 2012 and none of us could have predicted how transformative it has been.” The CRISPR-Cas9 system has already proven to be a powerful research tool, and also shows promise as a method for gene therapy to treat cystic fibrosis and blood disorders.
Other award recipients included neurosurgeon Alim Louis Benabid of Joseph Fourier University in France, for his work on deep-brain stimulation as a therapy for Parkinson’s disease, and Victor Ambros of the University of Massachusetts Medical School and Gary Ruvkun of Harvard Medical School for their research on gene regulation by microRNAs.
C. David Allis of The Rockefeller University in New York was recognized for his work on epigenetics—specifically, covalent modifications of histone proteins with broad effects on gene regulation and disease.
“When you decide to pursue a very basic problem in life sciences like gene regulation, you never expect to receive a prize as remarkable as the Breakthrough Prize. It shows how wonderful a career in science is,” Allis told The Guardian